News headlines about Constellium (NYSE:CSTM) have been trending somewhat positive this week, Accern reports. The research firm identifies negative and positive press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Constellium earned a news impact score of 0.14 on Accern’s scale. Accern also gave news coverage about the industrial products company an impact score of 46.3790625675889 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Here are some of the news articles that may have effected Accern’s rankings:
- Constellium (CSTM) Upgraded at ValuEngine (americanbankingnews.com)
- Risk Factors under Consideration – Constellium NV (NYSE: CSTM) (stocktradingpoint.com)
- Stock’s ATR Value in the Spotlight – Constellium (NYSE:CSTM) (thestockgem.com)
- Two Stable Stocks: Community Health Systems, Inc. (NYSE:CYH), Constellium NV (NYSE:CSTM) (oracleexaminer.com)
- Trader’s Roundup: Constellium NV (CSTM) – Post Registrar (postregistrar.com)
Constellium (NYSE CSTM) opened at $10.65 on Monday. The firm has a market cap of $1,124.45, a price-to-earnings ratio of -44.38 and a beta of 0.86. The company has a quick ratio of 0.68, a current ratio of 1.26 and a debt-to-equity ratio of -6.34. Constellium has a 1-year low of $5.35 and a 1-year high of $14.10.
CSTM has been the subject of a number of research analyst reports. Morgan Stanley lifted their target price on shares of Constellium from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Tuesday, February 6th. Cowen set a $20.00 target price on shares of Constellium and gave the stock a “buy” rating in a research report on Tuesday, February 6th. ValuEngine raised shares of Constellium from a “hold” rating to a “buy” rating in a research report on Friday, February 2nd. Goldman Sachs initiated coverage on shares of Constellium in a research report on Tuesday, March 20th. They issued a “buy” rating and a $16.00 target price for the company. Finally, Societe Generale downgraded shares of Constellium from a “buy” rating to a “hold” rating in a research report on Wednesday, February 28th. Five equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $14.60.
TRADEMARK VIOLATION WARNING: This story was first posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this story on another site, it was stolen and reposted in violation of United States and international trademark & copyright law. The original version of this story can be viewed at https://www.tickerreport.com/banking-finance/3301728/constellium-cstm-getting-somewhat-favorable-news-coverage-study-shows.html.
Constellium Company Profile
Constellium N.V. is a Netherlands-based company engaged in developing aluminum products for a range of markets and applications, including aerospace, automotive and packaging. The Company’s manufacturing facilities are located in the United States, Europe and China. It operates through three segments: Packaging & Automotive Rolled Product; Aerospace & Transportation, and Automotive Structures & Industry.
Receive News & Ratings for Constellium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Constellium and related companies with MarketBeat.com's FREE daily email newsletter.